Pulmonx Corp
LUNGNasdaqCIK 1127537HealthcareFiscal year ends Dec 31
All transactions: 10
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-07-13 | Boston Scientific Corp10% owner | Sale | 2,500,000 | $37.45 | $93.6m | Form 4 |
| 2021-04-06 | Boston Scientific Corp10% owner | Sale | 650,000 | $43.60 | $28.3m | Form 4 |
| 2021-03-30 | Boston Scientific Corp10% owner | Sale | 1,350,000 | $40.80 | $55.1m | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 542 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 6,215 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 23,180 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 40,705 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 47,536 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 2,081,909 | $0.00 | $0 | Form 4 |
| 2020-10-05 | Boston Scientific Corp10% owner | Conversion | 3,787,878 | $0.00 | $0 | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 16:08 ET. Listed shows no prices and gives no investment advice.